随着现代科学的发展，机器人辅助腹腔镜技术以其高清3D 手术视野、灵活的机械臂、颤抖滤除、精准定位操作、创伤小、恢复快等优势在泌尿外科的运用已逐渐成熟，但也面临不良事件、医疗公平、价格昂贵及法律责任认定等问题。本文对机器人辅助腹腔镜技术在泌尿外科手术的安全性和优势进行阐述，并展望其未来发展前景，以期为机器人辅助系统在泌尿外科的应用提供借鉴。

With the development of modern science, robot-assisted laparoscopic technology has been more and more widely applied in urologic surgery for its 3D high-definition surgical field, flexible mechanical arms, tremble filtering system,precise positioning, minimally invasive and quick recovery. However, it also faces problems such as adverse events, medical justice, high cost and liability determination. The safety and advantages of robot-assisted laparoscopic technology in urologic surgery were reviewed, and its future development was prospected in this paper, hoping to provide references for the application

of robot-assisted surgical system in urology.

收稿日期：2022-02-28  录用日期：2022-10-16 

Received Date: 2022-02-28  Accepted Date: 2022-10-16 

基金项目：重庆市科技攻关项目基金（应用技术研发类）（cstc2012gg-yyjs0454） 

Foundation Item: Chongqing Science and Technology Project Fund (Applied Technology Research and Development) (cstc2012gg-yyjs0454). 

通讯作者：王德林，Email：dlwangws@sina.com 

Corresponding Author: WANG Delin, Email: dlwangws@sina.com 

引用格式：魏华，王德林，甘祥芝，等 . 机器人辅助腹腔镜技术在泌尿外科的应用与展望 [J]. 机器人外科学杂志（中英文）， 2023，4（3）：177-185. 

Citation: WEI H, WANG D L, GAN X Z, et al. Application and prospects of robot-assisted laparoscopic technology in urology[J]. Chinese Journal of Robotic Surgery, 2023, 4 (3): 177-185.

[1] Koukourikis P, Rha K H. Robotic surgical systems in urology: what is currently available?[J].Investig Clin Urol, 2021, 62(1): 14-22.

[2] Kim D H, Kim H, Kwak S, et al. The settings, pros and cons of the new surgical robot da Vinci Xi system for transoral robotic surgery (TORS): a comparison with the popular da Vinci Si system[J]. Surg Laparosc Endosc Percutan Tech, 2016, 26(5): 391-396.

[3] Siegel R L, Miller K D, Fuchs H E, et al. Cancer Statistics, 2021[J].CA: A Cancer J Clin, 2021, 71(1):7-33.

[4] Hu J C, O’Malley P, Chughtai B, et. al. Comparative effectiveness of cancer control and survival after robotassisted versus open radical prostatectomy[J]. J Urol,2017, 197(1): 115-121.

[5] 王共先, 刘伟鹏, 周晓晨. 前列腺癌根治术入路的选择[J]. 临床泌尿外科杂志, 2018, 33(6): 423-427.

[6] Novara G, Ficarra V, Rosen R C, et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy[J]. Eur Urol, 2012, 62(3): 431-452.

[7] 张驰宇. 机器人辅助前列腺癌根治术与腹腔镜下前列腺癌根治术疗效比较的荟萃分析[D]. 南昌大学,2021.

[8] 王亚楠, 肖俊, 熊泽众, 等. 机器人辅助腹腔镜下前列腺癌根治术加扩大盆腔淋巴结清扫术治疗局部进展期前列腺癌的回顾性临床分析[J]. 临床泌尿外科杂志, 2021, 36(11): 847-850+855.

[9] HUNG C F, YANG C K, OU Y C. Robotic assisted laparoscopic radical prostatectomy following transurethral resection of the prostate: perioperative,oncologic and functional outcomes[J]. Prostate Int,2014, 2(2): 82-89.

[10] Novara G, Catto J W, Wilson T, et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot assisted radical cystectomy[J].Eur Urol, 2015, 67(3): 376-401.

[11] Satkunasivam R, Tallman C T, Taylor J M, et al.Robot-assisted radical cystectomy versus open radical cystectomy: a meta-analysis of oncologic, perioperative,and complication-related outcomes[J]. Eur Urol Oncol,2019, 2(4): 443-447.

[12] Kunath F. Robotic versus open radical cystectomy for adults with bladder cancer[J].Der Urologe, 2020, 59(5):595-599.

[13] Nguyen D P, Al Hussein Al Awamlh B, Charles Osterberg E, et al. Postoperative complications and short-term oncological outcomes of patients aged ≥ 80 years undergoing robot-assisted radical cystectomy[J].World J Urol, 2015, 33(9): 1315-1321.

[14] Lenfant L, Verhoest G, Campi R, et al. Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multiinstitutional french study[J]. World J Urol, 2018, 36(11):1711-1718.

[15] Ahmed K, Khan S A, Hayn M H, et al. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium[J]. Eur Urol, 2014, 65(2): 340-347.

[16] CAI Z Y, LI H H, HU J, et al. Intracorporeal versus extracorporeal urinary diversion after robot-assisted radical cystectomy: a pooled analysis[J]. Gland Sur,2021, 10(2): 706-720.

[17] Katayama S, Mori K, Pradere B, et al. Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and metaanalysis[J]. Int J Clin Oncol, 2021, 26(9): 1587-1599.

[18] Luciani L G, Chiodini S, Mattevi D, et al. Roboticassisted partial nephrectomy provides better operative outcomes as compared to the laparoscopic and open approaches: results from a prospective cohort study[J]. J Robot Sur, 2017, 11(3): 333-339.

[19] Masson-Lecomte A, Bensalah K, Seringe E, et al. A prospective comparison of surgical and pathological outcomes obtained after robot-assisted or pure laparoscopic partial nephrectomy in moderate

to complex renal tumours: results from a French multicentre collaborative study[J]. BJU Int, 2013,111(2): 256-263.

[20] 陈晶, 梁朝朝, 周骏, 等. 达芬奇机器人辅助腹腔镜泌尿外科手术500 例回顾性分析[J]. 微创泌尿外科杂志, 2018, 7(2): 77-82.

[21] Shuch B,Crispen P L , Leibovich B C , et al .Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality?[J]. BJU Int, 2011, 107(5): 724-728.

[22] WANG B J, HUANG Q B, LIU K, et al. Robotassisted level III-IV inferior vena cava thrombectomy:initial series with step-by-step procedures and 1-yr outcomes[J]. Eur Urol, 2020, 78(1): 77-86.

[23] GU L Y, MA X, GAO Y, et al. Robotic versus open level I-II inferior vena cava thrombectomy: a matched group comparative analysis[J]. J Urol, 2017, 198(6): 1241-1246.

[24] Materazzi G, Rossi L. Robot-assisted adrenalectomy:state of the art[J]. Updates Surg, 2021, 73(3): 1131-1146.

[25] Asher K P, Gupta G N, Boris R S, et al. Robotassisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique[J]. Eur Urol, 2011, 60(1): 118-124.

[26] 沈天一, 汤昊, 张征宇, 等. 机器人下自体口腔颊黏膜移植治疗输尿管长段狭窄4 例报告[J]. 微创泌尿外科杂志, 2021, 10(4): 217-220.

[27] Reddy M N, Nerli R B. The laparoscopic pyeloplasty:is there a role in the age of robotics? [J].Urol Clin North Am, 2015, 42(1): 43-52.

[28] 范阳, 董隽, 祖强, 等. 机器人患肾切取、工作台手术联合机器人自体肾移植术在复杂肾肿瘤保留肾单位手术中的应用[J]. 中华泌尿外科杂志, 2019,40(5): 340-345.

[29] Hoznek A, Zaki S K, Samadi D B, et al. Robotic assisted kidney transplantation: an initial experience[J]. J Urol,2002, 167(4): 1604-1606.

[30] Doumerc N, Roumiguie M, Beauval J B, et al. Robotic kidney transplantation for morbidly obese patients excluded from traditional transplantation[J]. Obes Surg,2017, 27(4): 1056-1057.

[31] Doumerc N, Roumiguie M, Rischmann P, et al. Totally robotic approach with transvaginal insertion for kidney transplantation[J]. Eur Urol, 2015, 68(6): 1103-1104.

[32] Vigués F, Bonet X, Etcheverry B, et al. Orthotopic robot-assisted kidney transplantation: first case report[J].World J Urol, 2021, 39(7): 2811-2813.

[33] U.S. Food and Drug Administration (2011) MAUDEManufacturer and User Facility Device Experience Database[EB/OL]. http: //www. accessdata. fda. gov/scripts/cdrh/cfdocs/cfmaude/search. cfm. Accessed 1 Jan 2019.

[34] Alemzadeh H, Raman J, Leveson N, Kalbarczyk Z, Iyer R K. Adverse events in robotic surgery: a retrospective study of 14 years of FDA Data[J]. PLoS One, 2016, 20,11(4): e0151470.

[35] Nik-Ahd F, Souders CP, Houman J, et al. Robotic urologic surgery : trends in Food and Drug Administration-reported adverse events over the last decade[J]. J Endourol, 2019, 33(8): 649-654.

[36] Childers C P, Maggard-Gibbons M. Estimation of the acquisition and operating costs for robotic surgery[J].JAMA, 2018, 320(8): 835-836.

[37] 王林辉. 机器人辅助腹腔镜技术在泌尿外科的临床应用: 中国15 年数据分析[J]. 第二军医大学学报,2020, 41(7): 697-700.

[38] 张旭, 范阳. 机器人手术在泌尿外科的应用现状与未来发展[J]. 加速康复外科杂志, 2021, 4(2): 49-54.

[39] 李恒爱, 卢建军, 熊莺. 不同术式治疗前列腺癌的住院费用分析[J]. 中国病案, 2016, 17(10): 58-60.

[40] 刘珍竹, 王建伯, 王雪剑. 达芬奇机器人手术在泌尿外科应用中的伦理问题及对策[J]. 医学与哲学,2021, 42(13): 24-27+31.

[41] 王涛. 微创手术机器人力反馈主手系统研究[D]. 哈尔滨工业大学, 2020.

[42] 毛德强. 微创手术机器人从手夹持力反馈研究[D].哈尔滨工业大学, 2021.

[43] Kaouk J H, Goel R K, Haber G P, et al. Robotic singleport transumbilical surgery in humans: initial report[J].BJU Int, 2009, 103(3): 366-369.

[44] 吴震杰, 孙颖浩. 泌尿外科机器人辅助单孔腹腔镜手术应用现状和展望[J]. 中华泌尿外科杂志, 2014,35(12): 945-948.

[45] 刘一帆, 高贺云, 张文, 等. 机器人辅助单孔腹腔镜下小婴儿肾盂成形术一例: 国内首例报道[J]. 机器人外科学杂志( 中英文), 2022, 3(2): 140-148.

[46] Intuitive Surgical I. Intuitive Surgical Announces Innovative Single Port Platform-the da Vinci SP®Surgical System. Intuitive Surgical [Internet] 2018[cited 2019 Sep 1]. Available online: http: //investor.

intuitivesurgical.com/news-releases/news-releasedetails/intuitive-surgical-announces-innovative-singleport-platform-da

[47] Billah M S, Stifelman M, Munver R, et al. Single port robotic assisted reconstructive urologic surgery-with the da Vinci SP surgical system[J]. Transl Androl Uro,2020, 9(2): 870-878.

[48] 朱刚, 邢金春, 翁国斌, 等. 全息影像术中导航在泌尿外科腹腔镜和机器人手术中的应用价值[J]. 中华泌尿外科杂志, 2020, 41(2): 131-137.

[49] 冯家乐, 程继文.3D 打印技术在前列腺癌诊疗中的研究进展[J]. 中国肿瘤外科杂志, 2021, 13(2): 206-208.

[50] JIN Y P, SHI C, WU Y Y, et al．Encapsulated three-dimensional bioprinted structure seeded with urothelial cells: a new construction technique for tissueengineered urinary tract patch[J]. Chin Med J, 2020,133( 4) : 424-434.

[51] 张强. 打造中国的“达芬奇” 国产单孔手术机器人把手术变“艺术”[N]. 科技日报, 2021-03-17(8).

[52] 李学松, 樊书菠, 熊盛炜, 等. 国产内窥镜手术机器人系统在肾部分切除术中的初步临床应用[J]. 中华泌尿外科杂志, 2021, 42(5): 375-380.

[53] 王延斌. 国产手术机器人“妙手”回春[N]. 科技日报, 2021-10-08(8).

[54] 马爱平. 国产手术机器人冲击“达芬奇”垄断地位[N]. 科技日报, 2021-10-13(8).